Patentability of antibodies for therapeutic use in Europe

General guidelines are presented on the types of patent protection available for inventions arising from research in the field of monoclonal antibodies, using concepts drawn from European case law and expert practice.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    European Patent Office. European Patent Convention, 15th edn (European Patent Office, 2013).

  2. 2

    Ballester Rodé s, A. et al. (eds) Case Law of the Boards of Appeal of the European Patent Office 8th edn, 275–278 (European Patent Office, 2016).

  3. 3

    Eli Lilly & Co. v. Human Genome Sciences Inc., C-493/12 (2013).

  4. 4

    European Patent Office. Guidelines for Examination in the European Patent Office 747–749 (European Patent Office, 2017).

  5. 5

    Art. 53(c) EPC.

  6. 6

    Arts. 54(4) and 54(5) EPC.

  7. 7

    EPO Board of Appeal decisions: T499/88 (EP59598: Immunoglobulins/Unilever), T36/90 (EP 676642: Tumor cells/Bogoch), T906/91 (EP 198179: Monoclonal antibody to theophylline/DuPont).

  8. 8

    EP 0865448 (12 June 1997).

  9. 9

    EPO Board of Appeal rulings: T355/92 (EP 193880: anti-FSH antibody (Boehringer Mannheim), T510/94 (EP 125722: Monoclonal antibody OKT5/ORTHO).

  10. 10

    Ballester Rodés, A. et al. (eds) Case Law of the Boards of Appeal of the European Patent Office 8th edn. 201–203 (European Patent Office, 2016).

  11. 11

    EPO Board of Appeal decision T1212/97 (EP1125023: Immunoglobulin preparation/Genentech).

  12. 12

    Art. 83 EPC.

  13. 13

    European Patent Office. Guidelines for Examination in the European Patent Office 689–691 (European Patent Office, 2012).

  14. 14

    Art. 56 EPC.

Download references

Author information

Correspondence to Patrizia Rampinelli.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Germinario, C., Bertoli, S., Rampinelli, P. et al. Patentability of antibodies for therapeutic use in Europe. Nat Biotechnol 36, 402–405 (2018). https://doi.org/10.1038/nbt.4134

Download citation

Further reading